Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nat Prod Res ; : 1-7, 2024 Jul 14.
Artigo em Inglês | MEDLINE | ID: mdl-39004890

RESUMO

This study involved the synthesis of a series of novel cannabidiol (CBD) aromatic ester derivatives, including CBD-8,12-diaromaticester derivatives (compounds 2a-2t) and CBD-8,12-diacetyl-21-aromaticester derivatives (compound 5a-5c). The antiproliferative activities of these compounds against human liver cancer cell lines HePG2 and HeP3B as well as human pancreatic cancer cell lines ASPC-1 and BXPC-3 were evaluated in vitro using the CCK-8 assay. The results indicated that compound 2f exhibited an IC50 value of 2.75 µM against HePG2, which is 5.32-fold higher than that of CBD. Additionally, compounds 2b and 5b demonstrated varying degrees of improved anticancer activity (IC50 5.95-9.21 µM) against HePG2.

2.
Artigo em Inglês | MEDLINE | ID: mdl-35410064

RESUMO

Currently, little is known about systematic comparisons of sludge products obtained from different sludge treatment processes in terms of land use. Moreover, it is worth evaluating whether the sludge produced from the co-treatment of industrial wastewater and domestic sewage can be applied to land use. In this study, three sludge products derived from the same municipal sludge-sludge biochar (SSB), dried sludge (DSS), and sludge compost (SSC)-were added to silty loam (SL) at a 20% mass ratio to assess their effects on soil structure, properties, and fertility. Chinese cabbage was planted as a model crop and its growth and physiological state were monitored. The experimental results showed that the water retention of the soil was significantly related to its porosity, and the moisture in the three sludge products-modified soil mainly existed in the form of free water. The addition of three sludge products increased the total porosity of SL. SSC enhanced the water retention of SL by increasing the capillary porosity, and SSB improved the gas permeability of SL by increasing the non-capillary porosity. The three sludge products all increased the content of large particles in the soil and improved the stability of the aggregates of SL. Among them, SSB and DSS had significant effects on improving the stability of the aggregates. Although the addition of the three sludge products improved the fertility of SL, compared with that of DSS and SSC, the addition of SSB made the growth indices of Chinese cabbage the best, indicating that SSB can effectively maintain soil nutrients. The heavy metal test results of Ni showed that SSB had a good stabilizing effect on heavy metals. Therefore, compared with drying and composting, pyrolysis of municipal sludge is more suitable for SL improvement.


Assuntos
Brassica , Metais Pesados , Poluentes do Solo , Metais Pesados/análise , Esgotos/química , Solo/química , Poluentes do Solo/análise , Águas Residuárias , Água
3.
Elife ; 72018 11 21.
Artigo em Inglês | MEDLINE | ID: mdl-30460894

RESUMO

Rotaviruses (RVs), a leading cause of severe diarrhea in young children and many mammalian species, have evolved multiple strategies to counteract the host innate immunity, specifically interferon (IFN) signaling through RV non-structural protein 1 (NSP1). However, whether RV structural components also subvert antiviral response remains under-studied. Here, we found that MAVS, critical for the host RNA sensing pathway upstream of IFN induction, is degraded by the RV RNA methyl- and guanylyl-transferase (VP3) in a host-range-restricted manner. Mechanistically, VP3 localizes to the mitochondria and mediates the phosphorylation of a previously unidentified SPLTSS motif within the MAVS proline-rich region, leading to its proteasomal degradation and blockade of IFN-λ production in RV-infected intestinal epithelial cells. Importantly, VP3 inhibition of MAVS activity contributes to enhanced RV replication and to viral pathogenesis in vivo. Collectively, our findings establish RV VP3 as a viral antagonist of MAVS function in mammals and uncover a novel pathogen-mediated inhibitory mechanism of MAVS signaling.


Assuntos
Proteínas Adaptadoras de Transdução de Sinal/genética , Proteínas do Capsídeo/genética , Interações Hospedeiro-Patógeno , Interferons/genética , Infecções por Rotavirus/genética , Rotavirus/genética , Proteínas Adaptadoras de Transdução de Sinal/imunologia , Animais , Células COS , Proteínas do Capsídeo/imunologia , Caspase 1/genética , Caspase 1/imunologia , Chlorocebus aethiops , Modelos Animais de Doenças , Células Epiteliais/imunologia , Células Epiteliais/virologia , Regulação da Expressão Gênica , Células HEK293 , Células HT29 , Humanos , Íleo/imunologia , Íleo/virologia , Interferons/imunologia , Camundongos , Células NIH 3T3 , Proteínas NLR/genética , Proteínas NLR/imunologia , Complexo de Endopeptidases do Proteassoma/metabolismo , Proteólise , Rotavirus/crescimento & desenvolvimento , Rotavirus/imunologia , Infecções por Rotavirus/imunologia , Infecções por Rotavirus/virologia , Transdução de Sinais , Interferon lambda
4.
Arthritis Res Ther ; 20(1): 132, 2018 07 04.
Artigo em Inglês | MEDLINE | ID: mdl-29973268

RESUMO

BACKGROUND: Chemerin is a chemoattractant involved in immunity that also functions as an adipokine. Chemerin is secreted as an inactive precursor (chem163S), and its activation requires proteolytic cleavages at its C-terminus, involving proteases in coagulation, fibrinolysis, and inflammation. Previously, we found chem158K was the dominant chemerin form in synovial fluids from patients with arthritis. In this study, we aimed to characterize a distinct cleaved chemerin form, chem156F, in osteoarthritis (OA) and rheumatoid arthritis (RA). METHODS: Purified chem156F was produced in transfected CHO cells. To quantify chem156F in OA and RA samples, we developed a specific ELISA for chem156F using antibody raised against a peptide representing the C-terminus of chem156F. RESULTS: Ca2+ mobilization assays showed that the EC50 values for chem163S, chem156F, and chem157S were 252 ± 141 nM, 133 ± 41.5 nM, and 5.83 ± 2.48 nM, respectively. chem156F was more active than its precursor, chem163S, but very much less potent than chem157S, the most active chemerin form. Chymase was shown to be capable of cleaving chem163S at a relevant rate. Using the chem156F ELISA we found a substantial amount of chem156F present in synovial fluids from patients with OA and RA, 24.06 ± 5.51 ng/ml and 20.35 ± 5.19 ng/ml (mean ± SEM, n = 25) respectively, representing 20% of total chemerin in OA and 76.7% of chemerin in RA synovial fluids. CONCLUSIONS: Our data show that chymase cleavage of chem163S to partially active chem156F can be found in synovial fluids where it can play a role in modulation of the inflammation in joints.


Assuntos
Artrite Reumatoide/metabolismo , Quimiocinas/metabolismo , Quimases/metabolismo , Peptídeos e Proteínas de Sinalização Intercelular/metabolismo , Osteoartrite/metabolismo , Precursores de Proteínas/metabolismo , Líquido Sinovial/metabolismo , Animais , Células CHO , Quimiocinas/genética , Cricetinae , Cricetulus , Ensaio de Imunoadsorção Enzimática , Humanos , Peptídeos e Proteínas de Sinalização Intercelular/genética , Isoformas de Proteínas/metabolismo , Proteínas Recombinantes/metabolismo
5.
Blood ; 131(3): 353-364, 2018 01 18.
Artigo em Inglês | MEDLINE | ID: mdl-29158361

RESUMO

Chemerin is a chemoattractant and adipokine that circulates in blood as inactive prochemerin (chem163S). Chem163S is activated by a series of C-terminal proteolytic cleavages resulting in diverse chemerin forms with different levels of activity. We screened a panel of proteases in the coagulation, fibrinolytic, and inflammatory cascades to identify those that process prochemerin in plasma. Factor XIa (FXIa) cleaved chem163S, generating a novel chemerin form, chem162R, as an intermediate product, and chem158K, as the final product. Processing at Arg162 was not required for cleavage at Lys158 or regulation of chemerin bioactivity. Contact phase activation of human platelet-poor plasma by kaolin led to cleavage of chem163S, which was undetectable in FXI-depleted plasma and markedly enhanced in platelet-rich plasma (PRP). Contact phase activation by polyphosphate in PRP resulted in 75% cleavage of chem163S. This cleavage was partially inhibited by hirudin, which blocks thrombin activation of FXI. After activation of plasma, levels of the most potent form of chemerin, chem157S, as well as inactive chem155A, increased. Plasma levels of chem163S in FXI-deficient patients were significantly higher compared with a matched control group (91 ± 10 ng/mL vs 58 ± 3 ng/mL, n = 8; P < .01) and inversely correlated with the plasma FXI levels. Thus FXIa, generated on contact phase activation, cleaves chem163S to generate chem158K, which can be further processed to the most active chemerin form, providing a molecular link between coagulation and inflammation.


Assuntos
Coagulação Sanguínea , Quimiocinas/metabolismo , Fator XIa/metabolismo , Inflamação/patologia , Peptídeos e Proteínas de Sinalização Intercelular/metabolismo , Sequência de Aminoácidos , Arginina/metabolismo , Plaquetas/metabolismo , Micropartículas Derivadas de Células/metabolismo , Quimiocinas/sangue , Quimiocinas/química , Humanos , Hidrólise , Peptídeos e Proteínas de Sinalização Intercelular/sangue , Peptídeos e Proteínas de Sinalização Intercelular/química , Cinética , Peptídeos/química , Peptídeos/metabolismo , Fosfolipídeos/metabolismo , Isoformas de Proteínas/sangue
6.
PLoS One ; 9(4): e95926, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24788338

RESUMO

The functionally undefined Stac3 gene, predicted to encode a SH3 domain- and C1 domain-containing protein, was recently found to be specifically expressed in skeletal muscle and essential to normal skeletal muscle development and contraction. In this study we determined the potential role of Stac3 in myoblast proliferation and differentiation, two important steps of muscle development. Neither siRNA-mediated Stac3 knockdown nor plasmid-mediated Stac3 overexpression affected the proliferation of C2C12 myoblasts. Stac3 knockdown promoted the differentiation of C2C12 myoblasts into myotubes as evidenced by increased fusion index, increased number of nuclei per myotube, and increased mRNA and protein expression of myogenic markers including myogenin and myosin heavy chain. In contrast, Stac3 overexpression inhibited the differentiation of C2C12 myoblasts into myotubes as evidenced by decreased fusion index, decreased number of nuclei per myotube, and decreased mRNA and protein expression of myogenic markers. Compared to wild-type myoblasts, myoblasts from Stac3 knockout mouse embryos showed accelerated differentiation into myotubes in culture as evidenced by increased fusion index, increased number of nuclei per myotube, and increased mRNA expression of myogenic markers. Collectively, these data suggest an inhibitory role of endogenous Stac3 in myoblast differentiation. Myogenesis is a tightly controlled program; myofibers formed from prematurely differentiated myoblasts are dysfunctional. Thus, Stac3 may play a role in preventing precocious myoblast differentiation during skeletal muscle development.


Assuntos
Diferenciação Celular/fisiologia , Fibras Musculares Esqueléticas/citologia , Mioblastos/citologia , Proteínas do Tecido Nervoso/fisiologia , Proteínas Adaptadoras de Transdução de Sinal , Animais , Sequência de Bases , Linhagem Celular , Primers do DNA , Camundongos , Reação em Cadeia da Polimerase
7.
Mol Cell Endocrinol ; 372(1-2): 23-9, 2013 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-23541948

RESUMO

The objective of this study was to identify the signaling pathways mediating the effects of IGF-I on muscle cell proliferation, protein synthesis, and protein degradation in a physiologically more relevant muscle cell model. We isolated muscle satellite cells from adult cattle and expanded them as myoblasts or induced them to form myotubes in culture. We determined the effects of IGF-I on proliferation of myoblasts and protein synthesis and degradation in myotubes in the presence or absence of specific signaling inhibitors. Our data suggest that both the MEK/ERK and PI3K/AKT pathways mediate the stimulatory effect of IGF-I on myoblast proliferation and that the PI3K/AKT pathway mediates this effect through cyclin D2. Our data also suggest that both the MEK/ERK and PI3K/AKT pathways mediate the stimulatory effect of IGF-I on protein synthesis through p70S6K and that the PI3K/AKT pathway mediates the inhibitory effect of IGF-I on protein degradation through FoxO3a.


Assuntos
Fator de Crescimento Insulin-Like I/fisiologia , Sistema de Sinalização das MAP Quinases , Células Satélites de Músculo Esquelético/metabolismo , Animais , Bovinos , Proliferação de Células , Células Cultivadas , Ciclina D2/genética , Ciclina D2/metabolismo , Fatores de Transcrição Forkhead/metabolismo , Expressão Gênica , Mioblastos Esqueléticos/metabolismo , Fosfatidilinositol 3-Quinases/metabolismo , Fosforilação , Cultura Primária de Células , Biossíntese de Proteínas , Processamento de Proteína Pós-Traducional , Proteólise , Proteínas Quinases S6 Ribossômicas 70-kDa/metabolismo , Ativação Transcricional
8.
PLoS One ; 8(4): e62760, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23626854

RESUMO

The goal of this study was to identify novel factors that mediate skeletal muscle development or function. We began the study by searching the gene expression databases for genes that have no known functions but are preferentially expressed in skeletal muscle. This search led to the identification of the Src homology three (SH3) domain and cysteine rich (C1) domain 3 (Stac3) gene. We experimentally confirmed that Stac3 mRNA was predominantly expressed in skeletal muscle. We determined if Stac3 plays a role in skeletal muscle development or function by generating Stac3 knockout mice. All Stac3 homozygous mutant mice were found dead at birth, were never seen move, and had a curved body and dropping forelimbs. These mice had marked abnormalities in skeletal muscles throughout the body, including central location of myonuclei, decreased number but increased cross-sectional area of myofibers, decreased number and size of myofibrils, disarrayed myofibrils, and streaming Z-lines. These phenotypes demonstrate that the Stac3 gene plays a critical role in skeletal muscle development and function in mice.


Assuntos
Desenvolvimento Muscular/genética , Músculo Esquelético/metabolismo , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/metabolismo , Proteínas Adaptadoras de Transdução de Sinal , Animais , Regulação da Expressão Gênica , Ordem dos Genes , Marcação de Genes , Genes Letais , Genótipo , Camundongos , Camundongos Knockout , Músculo Esquelético/patologia , Mutação , Miofibrilas/metabolismo , Miofibrilas/patologia , Miofibrilas/ultraestrutura , RNA Mensageiro/genética
9.
J Biol Chem ; 287(49): 40898-906, 2012 Nov 30.
Artigo em Inglês | MEDLINE | ID: mdl-23038267

RESUMO

This manuscript concerns the tissue-specific transcription of mouse and cattle glutamate decarboxylase-like protein 1 (GADL1) and the biochemical activities of human GADL1 recombinant protein. Bioinformatic analysis suggested that GADL1 appears late in evolution, only being found in reptiles, birds, and mammals. RT-PCR determined that GADL1 mRNA is transcribed at high levels in mouse and cattle skeletal muscles and also in mouse kidneys. Substrate screening determined that GADL1, unlike its name implies, has no detectable GAD activity, but it is able to efficiently catalyze decarboxylation of aspartate, cysteine sulfinic acid, and cysteic acid to ß-alanine, hypotaurine, and taurine, respectively. Western blot analysis verified the presence of GADL1 in mouse muscles, kidneys, C2C12 myoblasts, and C2C12 myotubes. Incubation of the supernatant of fresh muscle or kidney extracts with cysteine sulfinic acid resulted in the detection of hypotaurine or taurine in the reaction mixtures, suggesting the possible involvement of GADL1 in taurine biosynthesis. However, when the tissue samples were incubated with aspartate, no ß-alanine production was observed. We proposed several possibilities that might explain the inactivation of ADC activity of GADL1 in tissue protein extracts. Although ß-alanine-producing activity was not detected in the supernatant of tissue protein extracts, its potential role in ß-alanine synthesis cannot be excluded. There are several inhibitors of the ADC activity of GADL1 identified. The discovery of GADL1 biochemical activities, in conjunction with its expression and activities in muscles and kidneys, provides some tangible insight toward establishing its physiological function(s).


Assuntos
Carboxiliases/fisiologia , Glutamato Descarboxilase/metabolismo , Taurina/biossíntese , Animais , Carboxiliases/genética , Carboxiliases/metabolismo , Linhagem Celular , Ácido Cisteico/metabolismo , Cisteína/análogos & derivados , Cisteína/metabolismo , Rim/metabolismo , Cinética , Camundongos , Modelos Biológicos , Músculos/metabolismo , Mioblastos/metabolismo , Proteínas Recombinantes/metabolismo , Especificidade por Substrato , Taurina/análogos & derivados , Taurina/metabolismo , Distribuição Tecidual , beta-Alanina/metabolismo
10.
Endocrinology ; 153(2): 750-8, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22166977

RESUMO

Fibroblast growth factor 21 (FGF21) is a recently discovered metabolic regulator. Interestingly, FGF21 is also known to inhibit Janus kinase 2 (JAK2)-signal transducer and activator of transcription 5 (STAT5) signaling from the GH receptor in the liver, where FGF21 mRNA is predominantly expressed. In this study, we tested the hypothesis that FGF21 gene expression in the liver is controlled by GH through STAT5. We found that GH injection to cattle increased FGF21 mRNA expression in the liver. Mapped by a 5'-rapid amplification of cDNA ends assay, transcription of the FGF21 gene in the bovine liver was mainly initiated from a nucleotide 24 bp downstream of a TATA box. The bovine FGF21 promoter contains three putative STAT5-binding sites. EMSA confirmed the ability of them to bind to liver STAT5 protein from GH-injected cattle. Chromatin immunoprecipitation assays demonstrated that GH administration increased the binding of STAT5 to the FGF21 promoter in the liver. Cotransfection analyses showed that GH induced reporter gene expression from the FGF21 promoter in a STAT5-dependent manner. GH also stimulated FGF21 mRNA expression in cultured mouse hepatocytes. These data together indicate that GH directly stimulates FGF21 gene transcription in the liver, at least in part, through STAT5. This finding, together with the fact that FGF21 inhibits GH-induced JAK2-STAT5 signaling in the liver, suggests a novel negative feedback loop that prevents excessive JAK2-STAT5 signaling from the GH receptor in the liver.


Assuntos
Fatores de Crescimento de Fibroblastos/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Hormônio do Crescimento/farmacologia , Fígado/efeitos dos fármacos , Fator de Transcrição STAT5/metabolismo , Animais , Sequência de Bases , Sítios de Ligação , Bovinos , Células Cultivadas , Preparações de Ação Retardada , Feminino , Fatores de Crescimento de Fibroblastos/genética , Hormônio do Crescimento/administração & dosagem , Hepatócitos/fisiologia , Injeções Subcutâneas , Janus Quinase 2/genética , Janus Quinase 2/metabolismo , Fígado/metabolismo , Camundongos , Regiões Promotoras Genéticas , Ligação Proteica , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Receptores da Somatotropina/metabolismo , Proteínas Recombinantes , Fator de Transcrição STAT5/genética
11.
J Biomed Res ; 25(6): 438-43, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23554722

RESUMO

Phosphatase of regenerating liver-3 (PRL-3) is a member of the protein tyrosine phosphatase (PTP) superfamily and is highly expressed in cancer metastases. For better understanding of the role of PRL-3 in tumor metastasis, we applied a rapid and efficient method for generating PRL-3 floxed mice and investigated its phenotypes. A BAC retrieval strategy was applied to construct the PRL-3 conditional gene-targeting vector. Exon 4 was selected for deletion to generate a nonfunctional prematurely terminated short peptide as it will cause a frame-shift mutation. Conditional knockout PRL-3 mice were generated by using the Cre-loxP system and were validated by Southern blot and RT-PCR analysis. Further analysis revealed the phenotype characteristics of PRL-3 knockout mice and wildtype mice. In this study, we successfully constructed the PRL-3 conditional knockout mice, which will be helpful to clarify the roles of PRL-3 and the mechanisms in tumor metastasis.

12.
Mol Endocrinol ; 23(12): 2026-37, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19819986

RESUMO

IGF-I is abundantly expressed in the liver under the stimulation of GH. We showed previously that expression of hepatocyte nuclear factor (HNF)-3gamma, a liver-enriched transcription factor, was strongly stimulated by GH in bovine liver. In this study, we determined whether GH-increased HNF-3gamma might contribute to GH stimulation of IGF-I gene expression in bovine liver and the underlying mechanism. A sequence analysis of the bovine IGF-I promoter revealed three putative HNF-3 binding sites, which all appear to be conserved in mammals. Chromatin immunoprecipitation assays showed that GH injection increased binding of HNF-3gamma to the IGF-I promoter in bovine liver. Gel-shift assays indicated that one of the three putative HNF-3 binding sites, HNF-3 binding site 1, bound to the HNF-3gamma protein from bovine liver with high affinity. Cotransfection analyses demonstrated that this HNF-3 binding site was essential for the transcriptional response of the IGF-I promoter to HNF-3gamma in CHO cells and to GH in primary mouse hepatocytes. Using similar approaches, we found that GH increased binding of the signal transducer and activator of transcription 5 (STAT5) to the HNF-3gamma promoter in bovine liver, that this binding occurred at a conserved STAT5 binding site, and that this STAT5 binding site was necessary for the HNF-3gamma promoter to respond to GH. Taken together, these results suggest that in addition to direct action, GH-activated STAT5 may also indirectly stimulate IGF-I gene transcription in the liver by directly enhancing the expression of the HNF-3gamma gene.


Assuntos
Regulação da Expressão Gênica , Hormônio do Crescimento/farmacologia , Fator 3-gama Nuclear de Hepatócito/metabolismo , Fator de Crescimento Insulin-Like I/genética , Fator de Transcrição STAT5/metabolismo , Animais , Sítios de Ligação , Células CHO , Bovinos , Células Cultivadas , Imunoprecipitação da Cromatina , Cricetinae , Cricetulus , Ensaio de Desvio de Mobilidade Eletroforética , Feminino , Camundongos , Reação em Cadeia da Polimerase , Regiões Promotoras Genéticas/genética , Ligação Proteica/efeitos dos fármacos
13.
J Biomed Sci ; 15(1): 47-59, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17710565

RESUMO

N-ethyl-N-nitrosourea (ENU) mutagenesis is a phenotype-driven approach with potential to assign function to every locus in the mouse genome. In this article, we describe a new mutation, Pug, as a mouse model for X-linked hypophosphatemic rickets (XLH) in human. Mice carrying the Pug mutation exhibit abnormal phenotypes including growth retardation, hypophosphatemia and decreased bone mineral density (BMD). The new mutation was mapped to X-chromosome between 65.4 cM and 66.6 cM, where Phex gene resides. Sequence analysis revealed a unique T-to-C transition mutation resulting in Phe-to-Ser substitution at amino acid 80 of PHEX protein. In vitro studies of Pug mutation demonstrated that PHEX(pug) was incompletely glycosylated and sequestrated in the endoplasmic reticulum region of cell, whereas wild-type PHEX could be fully glycosylated and transported to the plasma membrane to exert its function as an endopeptidase. Taken together, the Pug mutant directly confirms the role of Phex in phosphate homeostasis and normal skeletal development and may serves as a new disease model of human hypophosphatemic rickets.


Assuntos
Raquitismo Hipofosfatêmico Familiar/enzimologia , Raquitismo Hipofosfatêmico Familiar/genética , Doenças Genéticas Ligadas ao Cromossomo X , Endopeptidase Neutra Reguladora de Fosfato PHEX/genética , Endopeptidase Neutra Reguladora de Fosfato PHEX/metabolismo , Mutação Puntual , Sequência de Aminoácidos , Substituição de Aminoácidos , Animais , Sequência de Bases , Linhagem Celular , Mapeamento Cromossômico , Clonagem Molecular , Primers do DNA/genética , Modelos Animais de Doenças , Raquitismo Hipofosfatêmico Familiar/patologia , Glicosilação , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Mutantes , Dados de Sequência Molecular , Endopeptidase Neutra Reguladora de Fosfato PHEX/química , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Homologia de Sequência de Aminoácidos , Transfecção , Cromossomo X/genética
14.
Physiol Genomics ; 31(2): 252-63, 2007 Oct 22.
Artigo em Inglês | MEDLINE | ID: mdl-17652166

RESUMO

Mutants of brain-derived neurotrophic factor (BDNF) are associated with obesity. However, the regulatory mechanism of BDNF expression is still unclear. We developed a novel mutant mouse line, transgenic insertional mutants with obesity, named Timo, in which a potential regulatory locus of Bdnf was disrupted by transgene insertion. The insertion site was identified and lies 857 kb upstream of the Bdnf gene. The disrupted genomic locus is conserved across the mouse, rat, dog, and human genome and contains several highly conserved elements that are able to upregulate reporter gene expression in vitro. Along with downregulation of BDNF to approximately 30% of wild-type animals, Timo/Timo mice exhibited increased body weight and fat content with hepatic steatosis and elevated serum levels of leptin, cholesterol, and LDL cholesterol. These mutant mice also showed obesity-independent insulin resistance, hyperinsulinemia, impaired glucose tolerance, age-dependent hyperglycemia, and shortened life span. Molecular and phenotype analysis of Timo/Timo mice indicated the existence of a genome locus, lying 857 kb upstream of the Bdnf gene, that regulates BDNF expression, body weight, and glucose homeostasis.


Assuntos
Fator Neurotrófico Derivado do Encéfalo/genética , Diabetes Mellitus Tipo 2/genética , Genes Reguladores/genética , Obesidade/genética , Animais , Fator Neurotrófico Derivado do Encéfalo/biossíntese , Linhagem Celular , Mapeamento Cromossômico , Sequência Conservada , Cruzamentos Genéticos , Diabetes Mellitus Tipo 2/sangue , Feminino , Genes Reporter , Humanos , Hiperfagia/genética , Resistência à Insulina/genética , Fígado/metabolismo , Longevidade/genética , Masculino , Mamíferos/genética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Camundongos Mutantes , Camundongos Transgênicos , Mutagênese Insercional , Obesidade/sangue , Especificidade da Espécie , Transgenes
15.
Am J Pathol ; 164(6): 2039-54, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15161639

RESUMO

Recent reports suggested that phosphatase of regenerating liver (PRL)-3 might be involved in colorectal carcinoma metastasis with an unknown mechanism. Here we demonstrated that PRL-3 expression was up-regulated in human liver carcinoma compared with normal liver. PRL-3 was also highly expressed in metastatic melanoma B16-BL6 cells but not in its lowly metastatic parental cell line, B16 cells. B16 cells transfected with PRL-3 cDNA displayed morphological transformation from epithelial-like shape to fibroblast-like shape. PRL-3-overexpressed cells showed much higher migratory ability, which could be reversed by specific anti-sense oligodeoxynucleotide and the phosphatase inhibitors sodium orthovanadate or potassium bisperoxo oxovanadate V. Meanwhile, the expression of the catalytically inactive PRL-3 mutations (D72A or C104S) significantly reduced the cell migratory capability. In addition, PRL-3 transfectants demonstrated altered extracellular matrix adhesive property and up-regulated integrin-mediated cell spreading efficiency. Furthermore, we confirmed that PRL-3 could facilitate lung and liver metastasis of B16 cells in an experimental metastasis model in mice, consistent with accelerated proliferation and growth rate both in vitro and in vivo. Together, these observations provide convincing evidence that PRL-3 truly plays a causal role in tumor metastasis.


Assuntos
Movimento Celular/fisiologia , Proteínas Imediatamente Precoces/metabolismo , Fígado/enzimologia , Melanoma Experimental/patologia , Melanoma Experimental/fisiopatologia , Metástase Neoplásica/patologia , Monoéster Fosfórico Hidrolases/metabolismo , Proteínas Tirosina Fosfatases/metabolismo , Animais , Sequência de Bases , Divisão Celular , Clonagem Molecular , Primers do DNA , DNA Complementar , Humanos , Proteínas Imediatamente Precoces/genética , Cinética , Neoplasias Hepáticas/enzimologia , Neoplasias Hepáticas/patologia , Camundongos , Camundongos Endogâmicos C57BL , Invasividade Neoplásica , Proteínas de Neoplasias , Monoéster Fosfórico Hidrolases/genética , Proteínas Tirosina Fosfatases/genética , Proteínas Recombinantes/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...